Stock viewMint
Why Sun Pharma Advanced Research shares surge 11% despite weak sentiments on D-Street; what's boosting medical stock?
Positive0
GreyOak summary
Sun Pharma Advanced Research (SPARC) shares jumped 11.30% to an intraday high of ₹219.49, defying broader market weakness. The company reported a Q2 FY27 net loss of ₹24.39 crore, narrowing from ₹75.85 crore previously, while revenue surged 282.1% to ₹30.03 crore. Meanwhile, the Sensex fell 93.95 points and Nifty 50 declined 30 points due to IT sector selling.
What it affects
Shares surged 11.30% despite weak market sentiment.Rolling sentiment Neutral 0
Source
Read the original at MintMore Sun Pharma Advanced Research Company news
No other recent stories about Sun Pharma Advanced Research Company.
All Sun Pharma Advanced Research Company news →